Influence of immunological nutrition on treatment of patients with oncological profile

Journal Title: Perioperative medicine - Year 2018, Vol 1, Issue 1

Abstract

In the reviewed article, we consider epidemiological and laboratory data that confirm the protective effects of biologically active nutrients in our diet for various diseases. Along with various factors such as alcohol, smoking, nutrition plays a vital role in influencing the patient’s immune response by transforming cells or by preventing, or acceleration of malignancy. Many data suggest that immunoactive nutrients control inflammatory and precancerous reactions in immune cells. Immunoprophylaxis is usually associated with modulation of the immune response when inflamed, thereby improving clinical outcomes. Different nutrients, including glutamine, arginine, vitamins, minerals and long-chain fatty acids, are important components of immunological nutrition. Clinical studies associated with these substances show different results with minimal effect. However, some studies have shown that these nutrients may have immunomodulatory effects that can reduce the risk of developing cancer. Pre-clinical studies claim that most of these nutrients have a positive effect in the complex treatment of cancer patients. In this article, we will consider the effect of the above nutrients on the immune system in patients of oncologic profile. Recent evidences suggest that immunological nutrition plays an important role in the development of cancer and its progression. Data from animal studies have clearly shown that the use of immunomodulatory nutrients isolated from food, by launching a cascade of immunological reactions, can detect and eliminate the tumor. Although the technology has evolved to such an extent that we can study each individual cytokine or function of the immune cell, it is difficult to demonstrate the powerful role of the immune system in preventing or treating cancer due to the complexity of the tumor cell or heterogeneity in different patients' populations. However, the study sheds light on interactions in immune responses and cancer development, prevention and therapeutic strategies that involve modulation through biologically active agents.

Authors and Affiliations

M. O. Katrichenko, I. I. Lisnyi

Keywords

Related Articles

Сепсис в акушерстві та гінекології

Незважаючи на певні успіхи сучасної медицини, частота запальних захворювань у жінок не знижується, а інфекційні ускладнення продовжують займати провідне місце в структурі акушерської та гінекологічної патології. Більш то...

Propofol in modern multicomponent general anesthesia

This article examines the use of propofrol in the perioperative period. It is known that one of the main principles of modern anesthesiology is to ensure maximum safety of the patient during and after anesthesia. As the...

Possibilities of ultrasound in perioperative medicine. A tribute to fashion or the need for clinical search for a surgeon?

This article discusses the possibilities of ultrasound in perioperative medicine, namely in the ultrasound study of the superficial organs, lungs, thyroid gland and other internal organs. This article presents sonograms...

Влияние иммунологического питания на лечение больных онкологического профиля

В обзорной сттатье рассмотрены эпидемиологические и лабораторные данные, которые подтверждают защитные эффекты биологически активных нутриентов в нашем рационе при различных заболеваниях. Наряду с различными факторами, т...

Антибіотикорезистентність Acinetobacter baumannii як збудника хірургічної інфекції та підходи до її подолання з використанням антисептика декаметоксину

У статті подано результати дослідження чутливості ізолятів Acinetobacter baumannii щодо бета-лактамних антибіотиків (ампіцилін-сульбактам, цефоперазон, цефоперазон-сульбактам, меропенем, іміпенем), амікацину, фторхінолон...

Download PDF file
  • EP ID EP341790
  • DOI 10.31636/prmd.v1i1.3
  • Views 88
  • Downloads 0

How To Cite

M. O. Katrichenko, I. I. Lisnyi (2018). Influence of immunological nutrition on treatment of patients with oncological profile. Perioperative medicine, 1(1), 19-24. https://europub.co.uk/articles/-A-341790